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Abstract Malaria is caused by Plasmodium species, whose
transmission to vertebrate hosts is facilitated by mosquito
vectors. The transition from the cold blooded mosquito
vector to the host represents physiological stress to the
parasite, and additionally malaria blood stage infection is
characterised by intense fever periods. In recent years, it
has become clear that heat shock proteins play an essential
role during the parasite's life cycle. Plasmodium falciparum
expresses two prominent heat shock proteins: heat shock
protein 70 (PfHsp70) and heat shock protein 90 (PfHsp90).
Both of these proteins have been implicated in the
development and pathogenesis of malaria. In eukaryotes,
Hsp70 and Hsp90 proteins are functionally linked by an
essential adaptor protein known as the Hsp70–Hsp90
organising protein (Hop). In this study, recombinant P.
falciparum Hop (PfHop) was heterologously produced in E.
coli and purified by nickel affinity chromatography. Using
specific anti-PfHop antisera, the expression and localisation
of PfHop in P. falciparum was investigated. PfHop was
shown to co-localise with PfHsp70 and PfHsp90 in para-
sites at the trophozoite stage. Gel filtration and co-
immunoprecipitation experiments suggested that PfHop
was present in a complex together with PfHsp70 and
PfHsp90. The association of PfHop with both PfHsp70 and
PfHsp90 suggests that this protein may mediate the
functional interaction between the two chaperones.
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Abbreviations
Hsp70 Heat shock protein 70
Hsp90 Heat shock protein 90
Hop Hsp70–Hsp90 organising protein
Hsp40 Heat shock protein 40
YT medium Yeast–tryptophan medium
IPTG Isopropyl-1-thio-β-D-galactopyranoside
PBS Phosphate-buffered saline
PMSF Phenyl methyl sulfonyl fluoride
SDS-PAGE Sodium dodecyl sulphate-polyacrylamide
gel electrophoresis
GFP Green fluorescent protein
IgG Immunoglobulin G
his-tag Polyhistidine tag
ATP Adenosine triphosphate
ADP Adenosine diphosphate
TCA Trichloroacetic acid
HRP Horseradish peroxidase
IP Immunoprecipitation
OD Optical density
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Heat shock proteins occur in all known life forms, and their
main role is to facilitate the folding of other proteins both
under normal and stressful conditions. Consequently, some
heat shock proteins are induced by cellular stress, thus
protecting cells against adverse effects. The role of heat
shock proteins in the survival of intracellular parasites
extends beyond maintenance of proteostasis, as they are
also implicated in the development and pathogenesis of
these organisms (reviewed by Shonhai et al. (2011). The
aetiologicalagent ofmalaria tropica,Plasmodium falciparum,
develops and thrives under physiologically divergent
conditions throughout its life stages. Heat shock proteins are
thought to play an important role in the development of P.
falciparum as well as other human parasites (Sharma 1992;
Shonhai et al. 2007; Shonhai et al. 2011).
Heat shock protein 70 (Hsp70) and Hsp90 are some
of the most studied molecular chaperones, proteins
which themselves are responsible for the folding of
other proteins in the cell. Hsp70 binds non-native
proteins whilst substrates of Hsp90 are usually in
native-like forms (Wegele et al. 2006). Proteins that
require both Hsp70 and Hsp90 to fold are thus transferred
from Hsp70 to Hsp90 during the folding process.
Eukaryotic Hsp90 participates in the conformational
regulation of signal transduction molecules, such as
tyrosine kinases and steroid hormone receptors. For
example, steroid hormone receptors associate with Hsp90
in order for them to adopt conformational competence for
hormone binding (Dittmar and Pratt 1997).
In eukaryotes, the essential interaction between Hsp70
and Hsp90 is mediated by the Hsp70–Hsp90 organising
protein (Hop; Nicolet and Craig 1989). Both Hsp70 and
Hsp90 possess C-terminally located EEVD motifs that
interact with Hop via its tetratricopeptide repeat (TPR)
domains, TPR1 and TPR2A motifs, respectively (Scheufler
et al. 2000). It is most likely that the Hsp70–Hsp90
functional partnership in Plasmodium spp. facilitates the
folding of key proteins in the parasite cell, possibly those
involved in signal transduction. PfHsp90 is known to play
an essential role in the survival of the parasite and the
antibiotic geldanamycin is known to inhibit its function
(Banumathy et al. 2003).
Ofthesix Hsp70-likeproteinsencodedby the P. falciparum
genome, only the cytosol-nuclear localised chaperone,
PfHsp70 possess the EEVD motif (Shonhai et al. 2007)t h a t
is crucial for interaction between Hsp70 and Hop. PfHsp90
occurs in the cytosol and migrates to the nucleus in response
to heat stress (Acharya et al. 2007). Thus, PfHsp70 and
possibly PfHsp90 possibly cooperate in the parasite cell.
Although a Hop homologue (PF14_0324) has been identified
in the P. falciparum genome (Acharya et al. 2007), its
function has not been characterised. Banumathy et al. (2003)
observed the occurrence of PfHsp90 and PfHsp70 in
functional units that were complexed to two other species
of proteins with a molecular mass of around 50 and 60 kDa,
respectively. Although not directly verified by experimental
data, the authors proposed that the two proteins associating
with PfHsp70 and PfHsp90 were P. falciparum cyophilin and
PfHop. In addition, at least one TPR-rich protein, PP5
phosphatase from P. Falciparum, has been shown to interact
with PfHsp90 (Dobson et al. 2001; Kumar et al. 2003).
So far. there is no direct experimental evidence for the
existence of a functional PfHsp70–PfHsp90 partnership.
However, the presence of PfHsp90 and PfHsp70 in
common cellular compartments, coupled to data based on
predictive bioinformatics suggest that the two chaperones
may functionally interact through a PfHop-mediated path-
way (Pavithra et al. 2004). The possible existence of a Hop-
mediated Hsp70–Hsp90 partnership in P. falciparum is
important, given the essential roles of these proteins.
Indeed, this pathway has been proposed as a potential
anti-malarial drug target (Pesce et al. 2010; Shonhai 2010).
The aim of the current study was to investigate the role of
PfHop as a potential mediator of the PfHsp70–PfHsp90
pathway. We cloned, expressed and purified recombinant
PfHop protein to facilitate its further characterisation. We
further analysed the cellular localisation of PfHop and its
association with PfHsp70 and PfHsp90.
Materials and methods
Bioinformatics
To map out the TPR domains in PfHop, Clustal Walignments
of Hop homologues from Plasmodium species, human,
mouse and yeast were performed utilizing the Bioedit
program version 7.0.5.3 (Hall 1999). A three-dimensional
model of PfHop was generated by SWISS-MODEL (Arnold
et al. 2006;G u e xa n dP e i t s c h1997; Schwede et al. 2003).
T h ei m a g e sw e r es u b s e q u e n tly visualised using the
PyMol molecular graphics system, version 0.99rc6 (DeLano
2002).
Peptide-directed PfHop and PfHsp90 antibody design
and synthesis
Anti-peptide antibodies specific to PfHop (PlasmoDB
accession number: PF14_0324) and PfHsp90 (PlasmoDB
accession number, PF07_0029) were generated commercially
(Eurogentec) by immunisation of rabbits with the following
synthetic peptides: TGEGNDAEERQRQQR, corresponding
to amino acids 195–206 of the PfHop sequence and a mixture
of two peptides (CIRYESITDTQKLSAE and CPKRAPFDM
192 G.W. Gitau et al.FENRKKR), corresponding to amino acids 45–59 and 364–
377 of PfHsp90, respectively.
Cloning of PfHop, over-expression and purification
of PfHop
The coding sequence of PfHop (PlasmoDB accession number:
PF14_0324) was PCR amplified from 3D7 gDNA using
forward primer (5′-TGCATGCATGGTTAACAAAGAA
GAAGCTC-3′) with a SphI site (in bold) and reverse primer
(5′-TCTGCAGTTATCGTACCTTCAATATTCCAGC-3′)
with a PstI site (in bold) and inserted into the SphI/PstIs i t e s
of pQE30 (Qiagen). Plasmid integrity was verified by
restriction digest and automated DNA sequencing.
To facilitate purification of PfHop recombinant protein,
the protein was first overexpressed in E. coli XL1 Blue
cells. The E. coli XL1 Blue cells were first transformed
with pQE30/PfHop plasmid. Subsequently, one isolated
recombinant colony from the YT agar plate was inoculated
to YT broth containing 100 μg/ml ampicillin (Roth)
followed by incubation at 37°C shaking incubator. At
OD600 of 0.6, the cells were induced with 1 mM isopropyl-
β-D-1-thiogalactopyranoside [IPTG] (Roth). Five hours
after induction, the cells were harvested by centrifugation
at 5,000g for 20 min at 4°C. They were then re-suspended
in non-reducing lysis buffer (300 mM NaCl, 10 mM
imidazole, 10 mM Tris, pH 8.0, 1 mM phenylmethylsul-
phonyl fluoride [PMSF], and 1 mM lysozyme). Cell lysis
was allowed to proceed for 20 min at room temperature
(22°C), after which the lysate was frozen at −80°C,
overnight. The cells were then thawed by mild sonication
at amplitude setting of 50 for 7 cycles with 15-second pulse
and five-second rest after each cycle. Soluble cell extract
was derived after clarification by centrifugation at 5,000g
for 30 min at 4°C. The His-tagged PfHop protein that was
in the soluble cell extract was allowed to bind to nickel-
charged sepharose beads at 4°C for 4 h. The beads were
washed using wash buffer (10 mM Tris, pH 7.5, 300 mM
NaCl, 50 mM imidazole), and PfHop recombinant protein
was then eluted using elution buffer (10 mM Tris, pH 7.5,
300 mM NaCl, 1 M imidazole). The eluted protein was
extensively dialysed at 4°C against a storage buffer (10 mM
Tris, pH 7.5, 300 mM NaCl, 50 mM imidazole, 0.8 mM
DTT and 10% glycerol). The protein was subsequently
concentrated with polyethylene glycol.
Construction of plasmid expressing PfHop-GFP
ThePfHopcodingsequencewasamplifiedbyPCRfromgDNA
(clone 3D7) using forward primer (5′-GGCTCGAGATGGT
TAACAAAGAAGAAGCTCAGAG-3′)w i t haXhoI site (in
bold) and reverse primer (5′-GGCCTAGGTCGTACCTT
CAATATTCCAGC-3′)w i t haAvrII site (in bold). The
successful isolation and amplification of the PCR product
were confirmed by agarose gel electrophoresis. The PCR
product was recovered by gel purified and restricted with XhoI
and AvrII. The PfHop encoding segment was inserted into the
pARL-2-GFP vector (Przyborski et al. 2005)b e t w e e nXhoI
and AvrII restriction sites located in the multiple cloning site.
The product was inserted in frame with a downstream GFP
coding sequence to generate pARL-2-GFP/PfHop plasmid
construct. Diagnostic restriction digestions using XhoIa n d
AvrII were conducted to confirm the integrity of the pARL-2-
GFP/PfHop plasmid construct. The plasmid was also
sequenced to confirm that the PfHop encoding segment was
inserted in frame with the GFP encoding sequence.
Parasite culture and preparation of parasite fractions
P. falciparum 3D7 cells were cultured under standard
conditions (Przyborski et al. 2005; Trager and Jensen,
1976). Sychronised parasites were harvested using Gelafun-
din flotation at the trophoite stage. Trophozoite-infected
erythrocytes were subsequently washed in PBS (pH 7.4) and
lysed using saponin (0.1%). Lysis was allowed to proceed on
ice for 6 min with constant gentle mixing to facilitate the
lysis. Parasites were collected by centrifugation at 36,000g
for 30 min at 4°C followed by an extensive wash step using
PBS (pH 7.4). The parasite lysates were subjected to Western
analysis to confirm the expression of PfHop. A host cell
protein, glycophorin was also probed as a loading control.
Images were acquired using X-ray film (Fuji super RX).
Immunofluorescence assays
Immunofluorescence assays to investigate the localisation
of PfHop and PfHop-GFP in parasite-infected erythrocytes
were carried out as previously described (Spork et al.
2009). Following fixation of parasite-infected red blood
cells, localisation was examined using anti-PfHop primary
antibody (purified IgG fraction, 1:100; this study), poly-
clonal anti-PfHsp70 primary antibodies (1:1,000; Pesce et
al. 2008) or polyclonal rabbit anti-PfHsp90 antibody
(purified IgG fraction 1:100; this study). After extensive
washing steps, the erythrocytes were thereafter incubated
with cy3-conjugated goat anti-rabbit IgG secondary anti-
bodies (1:2,000; DAKO Hamburg, Germany) for 2 h at
room temperature. The erythrocytes were observed with
fluorescence microscope (cell observer) using a 63× oil
immersion objective. The images were acquired using
Axiovision software package version 4.8.2. Image J
software was used for pseudo-colouring and for preparation
of merged co-localisation images. Negative control samples
of erythrocytes incubated with respective rabbit pre-immune
serum and secondary antibody were used to validate the
specificity of the localisation signal.
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Size exclusion chromatography was conducted as previously
described (Pesce et al. 2008). Infected erythrocytes were
suspended in PBS (pH 7.4) containing 0.15% (w/v) saponin
for 10 min on ice followed by centrifugation at 5,000g for
5 min. The pellet fraction of the parasite was washed three
times with PBS (pH 7.4) followed by resuspension in
50 mM Tris, 150 mM NaCl (pH 7.4) including 1 mM
PMSF and protease inhibitor cocktail (Pierce) and three
freeze–thaw cycles. The parasite lysate was centrifuged at
20,000g for 20 min at 4°C to separate soluble parasite lysate
and cell debris. An aliquot containing 400 μgo ft o t a l
parasite lysate was injected into a 24-ml Superdex 200
column (GE Healthcare). Fractions of parasite cell lysate of
500 μl were recovered automatically. The proteins contained
in the fractions were precipitated with 10% (w/v) trichloro-
acetic acid (TCA) on ice for 30 min and centrifuged. The
protein pellet was subjected to Western analysis using anti-
PfHsp90, anti-PfHsp70, and anti-PfHop antibodies. The
secondary antibody used was HRP-conjugated goat anti-
rabbit IgG (Dako, Germany, 1:1:2,000).
Immunoprecipitation analysis
Parasites released by saponin lysis were resuspended in IP-
lysis buffer (150 mM NaCl, 50 mM Tris–HCl, 0.1% NP-40,
1 mM PMSF, and protease inhibitor cocktail (Pierce)), and
subjected to three freeze/thaw cycles. A soluble supernatant
was collected by centrifugation (4°C, 36,000×g). Anti-
PfHsp70 antisera were added and the sample split into two
aliquots. One aliquot was adjusted to 5 mM ATP and the
other received no extra ATP. Antibody binding was allowed
to occur overnight at 4°C on a rocking platform. Following
this, protein A/G beads (Pierce) were added, and binding
was allowed to proceed for 1 h. The immunoprecipitate was
then collected by centrifugation at 1,000×g for 5 min at 4°C
and the pellet washed extensively with PBS (pH 7.4) before
preparation of the samples for SDS-PAGE and Western
analysis. Specificity of binding was controlled by monitoring
binding to control agarose beads.
Results
Mapping of the TPR domains in PfHop
Based on the Clustal W alignments conducted, PfHop
possesses three TPR domains: an N-terminal TPR1 domain
composed of residues 7–121, a centrally located TPR2A, at
position 243–365 and a C-terminal TPR2B, at position
378–494 (Fig. 1). Residues that are known to be important
in the interaction of the TPR domains of mouse Hop with
either Hsp70 or Hsp90 (Odunuga et al. 2003) are also
conserved in PfHop (Fig. 1). Thus, based on sequence
alignment data, PfHop presents itself as a typical member
of these TPR-rich proteins. Although, Hop proteins whose
sequences were analysed appear generally conserved across
species, it is interesting to note that there is relative
variation between plasmodial Hop proteins in comparison
to the human, yeast and mouse homologues even within
important functional domains such as the TPR segments
and DP motifs (Fig. 1; Carrigan et al. 2005). DP motifs are
known to be important in the global fold of Hop and their
disruption has been found to impair Hop function (Nelson
et al. 2003).
The concave surfaces that are formed by the TPR
domains of Hop provide interactive sites that can accom-
modate specific peptide binding (Scheufler et al. 2000).
Based on the three-dimensional model of TPR1 and
TPR2A domains, PfHop possesses conserved residues in
TPR1 (K11, N15) and TPR2A (K247, N251, K319) that are
implicated in the interaction of Hop with Hsp70 and Hsp90
chaperones, respectively (Fig. 2; Scheufler et al. 2000;
Odunuga et al. 2004). These residues appear to be surface-
exposed on the TPR helical domains, suggesting that they
may play an important role in binding PfHsp70 and
PfHsp90 chaperones.
Overexpression and purification of recombinant PfHop
Recombinant PfHop protein was expressed in E. coli XL1
Blue cells as a species of approximately 66 kDa (Fig. 3).
However, we also noticed a protein species of approximately
55 kDa, produced in E. coli together with the full length
PfHop recombinant protein. The expressed lower molecular
weight species, like the full length PfHop protein was
produced upon induction of the cells with IPTG and did
not appear in the control cells. Anti-PfHop antibodies were
able to recognize both the full length Hop protein and the
lower molecular weight species as confirmed by Western
blotting (Fig. 3b). We concluded that the lower molecular
species was either a truncated version of the full length
PfHop protein or a product of an incomplete synthesis. We
proceeded to purify PfHop by nickel affinity chromatography
and were able to recover the full length PfHop protein
(Fig. 3a). Fortunately, the species of lower molecular weight
did not co-purify with PfHop protein, suggesting that this
species had no polyhistidine tag attached (Fig. 3a, c).
Therefore, it is likely that the species of lower molecular
weight was an N-terminally truncated version of PfHop.
Localisation of PfHop
The localisation of PfHop in P. falciparum cells at the
trophozoite stage was investigated by immunofluorescence
194 G.W. Gitau et al.analysis (IFA) using anti-PfHop antibodies that we devel-
oped (Fig. 4a). The fluorescence signal (red signal) was
observed in the cytosol of parasites that had been cultured
at 37°C. To further investigate the cellular localisation of
PfHop, we created a transgenic parasite line expressing
PfHop attached to a C-terminal GFP tag. PfHop-GFP
localised largely to the body of the parasite (Fig. 4b). The
GFP signal was not detected in the nucleus, suggesting that
PfHop may not localise to the nucleus under normal growth
conditions. By indirect immunofluorescence, we investigat-
ed whether PfHop-GFP co-localises with PfHsp90. It
appears that PfHop-GFP and PfHsp90 co-localise in the
cytosol and their distribution assumed a uniform pattern in
the cell (Fig. 4c). PfHop-GFP and PfHsp70 co-localised in
the cytosol; however, they associated less uniformly than
PfHop-GFP and PfHsp90 (Fig. 4c, d). The expression of
PfHop-GFP by the transfected parasites was confirmed by
Western blot analysis (Fig. 4e). As loading control, a
Western blot was conducted using antibodies recognising P.
falciparum aldolase (Fig. 4e, third panel).
Fig. 1 Multiple sequence alignment of plasmodial, yeast and mamma-
lian Hop homlogues. Multiple sequence alignment of TPR domains of
Hop homologues from Pfal (Plasmodium falciparum, PlasmoDB
accession number, PF14_0324), Pviv (Plasmodium vivax,N C B I
accession number, XP_001616631.1), Pkno (Plasmodium knowlesi,
NCBI accession number, XP_002260669.1), Pcha (Plasmodium cha-
baudi, NCBI accession number, XP_745506.1), Pber (Plasmodium
berghei, NCBI accession number, XP_677465.1), Pyoe (Plasmodium
yoelii, NCBI accession number, XP_731105.1), Hsap (Homo sapiens,
NCBI accession number, NP_006810.1), Mmus (Mus musculus,N C B I
accession number, BC003794.1), and Scer (Saccharomyces cerevisiae,
NCBI accession number, CBZ50259.1). TPR domains are highlighted
as follows: TPR1 (red solid box), TPR2A (red dashed box) and TPR2B
[red dotted box] (Scheufler et al. 2000). Amino acids that are implicated
in TPR1–PfHsp70 and TPR2A–PfHsp90-1 interaction are indicated by
blue arrows (Scheufler et al. 2000; Odunuga et al. 2003; 2004).
Residues constituting DP1 and DP2 repeat (Carrigan et al. 2005) motifs
are highlighted by green rectangles
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and co-immunoprecipitation analysis
Size exclusion chromatography was performed to investigate
whether PfHop, PfHsp70, PfHsp90 and PfJ4, a potential
Hsp40co-chaperoneofPfHsp70(Pesceetal.2008) existed as
a complex in parasite cells. The eluted fractions obtained
were subjected to Western analysis using anti-PfHop, anti-
PfHsp70, anti-PfHsp90 and anti-PfJ4 antibodies (Pesce et al.
2008;F i g .5a). PfHsp90, PfHsp70 and PfHop all appeared in
an apparent fraction of approximately 400 kDa in size.
Several possibilities may underpin the observed findings.
One interpretation is that all the three proteins are in a
common complex. It is also possible that PfHsp90, PfHsp70
and PfHop may have been eluted in independent complexes
that were apparently of similar sizes, thus eluting in the same
fraction. Alternatively, this could represent independent
homo-oligomers that approximated each other in size, and
thus were eluted in the same fractions, but were not
necessarily associated with one another. A previous study
suggested that a type II (Cheetham and Caplan 1998) Hsp40
protein, PfJ4 associated with PfHsp70 (Pesce et al. 2008).
However, it seemed that PfJ4 was not part of the putative
complex made up of PfHop, PfHsp70 and PfHsp90 (Fig. 5a).
Formation of the Hsp70–Hop–Hsp90 complex is known
to be nucleotide sensitive. As a result, we sought to
establish whether PfHop, PfHsp70 and PfHsp90 association
was nucleotide-sensitive. A co-immunoprecipitation study
was conducted using anti-PfHsp70 antibodies and passing
parasite lysate through the column. In one instance, 5 mM
ATP was added to the parasite lysate before conducting the
immunoprecipitation (lane ‘+ATP’,F i g .5b)a n dt h e
Fig. 1 (continued)
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(lane ‘−ATP’, Fig. 5b). Hop associates preferably with
Hsp70 when the latter is bound to ADP. In the absence of
added ATP, it likely that most of the PfHsp70 protein in the
lysate was either bound to ADP or was in a nucleotide-free
state. In the absence of added ATP, PfHsp70 immunopre-
cipitated along with PfHop (lane ‘−ATP’, Fig. 5b). When
ATP was added to the lysate, we could not detect PfHop in
the PfHsp70 complex (lane ‘+ATP’, Fig. 5b). PfHsp90 was
detected when its association with PfHsp70 was investigat-
ed both in the presence and absence of added ATP. PfHsp90
appeared on the Western blot as a species of approximately
90 kDa (Fig. 5b). However, in the absence of ATP, more
PfHsp90 protein associated with PfHsp70 than when ATP
was added to the parasite lysate (Fig. 5b).
Discussion
PfHsp70 and PfHsp90 chaperones of Plasmodium spp. are
known to play essential roles in the development of the
parasites. PfHsp70 and PfHsp90 have been characterised
extensively and their roles in the development of P.
falciparum are well documented (Banumathy et al. 2003;
Sharma 1992; Shonhai et al. 2005; 2007). It is likely that
these chaperones are functionally linked. In mammals, the
TPR-rich Hop protein is known to modulate interaction of
Hsp70 and Hsp90 chaperones. To the best of our
knowledge, this is the first study to provide experimental
evidence suggesting a possible role for the P. falciparum
Hop homologue in mediating the functional partnership
between PfHsp70 and PfHsp90.
Based on bioinformatics analysis, PfHop possesses
conserved TPR1 and TPR2A domains that are implicated
in facilitating the interaction of Hop with Hsp70 and Hsp90
in mammalian cells (Fig. 1; Odunuga et al. 2003; 2004).
Residues that have direct contact with Hsp70 and Hsp90
are conserved in PfHop and they protrude on the helical
surfaces of the respective TPR domains (Fig. 2), thus
positioning them for the possible interaction of PfHop with
its chaperone clients. Overall, PfHop exhibits conserved
structural features of a typical Hop protein. However,
although most structural motifs are conserved in Hop
proteins, it is interesting to note that plasmodial Hop
proteins exhibit select distinct functional domains, com-
pared to their counterparts of yeast and mammalian origin.
The relative variations in sequences exhibited between
plasmodial Hop proteins and their counterparts from
mouse, human as well as yeast even in important domains
such as TPR and DP motifs (Fig. 1), could represent
potential functional variation in the Hop-mediated path-
ways in these species. For example, DP repeats have been
found to modulate Hop function by influencing the global
folding status of Hop (Nelson et al. 2003) and thus
variation within these domains could mirror functional
specialisation of Hop proteins. It is thought that the less
Fig. 2 PfHop model displays surface exposed residues implicated in
interaction with PfHsp70 and PfHsp90. Schematic representation of
PfHop showing the TPR domain as indicated by rectangles highlight-
ed in grey. The numbers represent the starting and the ending amino
acid residues of the three TPR domains. Ribbon representation of the
three dimensional models of TPR1, TPR2A and TPR2B domains.
Residues known to be crucial in the interaction of TPR1 and TPR2A
with Hsp70 and Hsp90, respectively are represented in sticks. The
models were generated by SWISS-MODEL (Arnold et al. 2006; Guex
and Peitsch 1997; Schwede et al. 2003) and rendered using PyMol
(DeLano 2002)
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have influence on the overall conformations of the
helical turns of the TPR domains, thus are capable of
imparting unique structural features to Hop molecules
from different species (D'Andrea and Regan 2003).
Therefore, the sequence variations observed between
PfHop and human Hop may make PfHop amenable for
selective inhibition using chemicals that may not interfere
with human counterpart.
In mouse cells, Hop predominantly occurs in the cytosol
under normal growth conditions and shuttles between the
nucleus and the cytosol (Lässle et al. 1997; Longshaw et al.
2000; 2004). An investigation into the cellular distribution
of PfHop in parasites at the trophozoite stage showed that
the protein is localised to the cytosol (Fig. 4). As PfHop is
implicated in mediating the interaction between PfHsp70
and PfHsp90, we investigated the distribution and co-
localisation of these three proteins. Indeed, PfHop dis-
played a similar cytosolic localisation profile to PfHsp90
(Fig. 5b), suggesting that the two proteins may associate.
Although, PfHop-GFP and PfHsp70 exhibited overlapping
cytosolic co-localisation signals, the PfHsp90–PfHop-GFP
co-localisation signal was more uniform than that for
PfHsp70–PfHop-GFP (Fig. 4b, c). It is possible that PfHop
associates more closely with PfHsp90 than with PfHsp70.
Cytosolic co-localisation of Hop and Hsp70 homologues
from Trypanosoma cruzi, another member of the apico-
complexan family, has been reported (Schmidt et al. 2011).
Previously, it was proposed that PfHsp70 and PfHsp90
were found to co-elute complexed to a 60 kDa species,
which was predicted to be PfHop (Banumathy et al. 2003).
Findings from this study point to the possible existence of a
PfHop-mediated partnership between PfHsp70 and
PfHsp90 as has been previously proposed (Pesce et al.
2010; Shonhai 2010).
We performed size exclusion chromatography to inves-
tigate if PfHop may occur in complexes with PfHsp90 and
PfHsp70 (Fig. 5a). We obtained fractions in which PfHop
was present along with PfHsp70 and PfHsp90. This
suggests the possible existence of a PfHsp70–PfHop–
PfHsp90 complex in P. falciparum. However, we cannot
formally rule out the possibility that the three proteins may
have occurred in independent complexes that may have
given rise to oligomeric units of similar apparent sizes.
Unusually, we also obtained a fraction containing a
complex of about 440 kDa in which PfHsp90 and PfHsp70
occurred in the absence of PfHop (Fig. 5a). Whilst this may
represent possible elution of PfHsp90 and PfHsp70 in
independent complexes, the interaction of Hsp70 and
Hsp90 through a Hop independent partnership has been
reported in other living organisms such as Neurospora
(Freitag et al. 1997). Interestingly, we also yielded several
fractions of varying sizes in which PfHsp70 and PfHop
occurred in the absence of PfHsp90. This was unexpected,
as it is known that Hsp90 improves the affinity of Hsp70
for Hop binding (Hernández et al. 2002a, b). However, it is
also known that binding of Hsp90 to Hsp70–Hop complex,
reduces the number of Hsp70 binding sites on Hop from
two to one binding site, although overall the binding of
Hsp90 improves affinity of Hsp70 for Hop (Hernández et
al. 2002b). Thus, Hsp90 binding may also be perceived as
putting a strain on the Hsp70–Hop complex. In addition, in
the absence of Hsp90, the Hsp70–Hop complex is stabilised
by other protein interactors, particularly Hsp40. This may
Fig. 3 Expression and purification of recombinant PfHop protein. a
SDS-PAGE analysis for the expression and purification of recombi-
nant PfHop protein. PfHop was expressed in E. coli XL1 Blue cells
transformed with pQE30/PfHop plasmid. Lane M represents molec-
ular weight markers (in kDa) as indicated on the left hand side; lane C,
represents the total extract for cells transformed with pQE30 plasmid
after IPTG induction; lane 0, represents total extract for cells
transformed with pQE30/PfHop plasmid prior to IPTG induction;
lanes 1–ON, represent total extract for cells transformed with pQE30/
PfHop plasmid collected hourly and overnight, respectively; lane F,
represents the flow through; lane W, represents wash sample; and lane
P, represents eluted PfHop protein. b Western analysis of PfHop using
anti-PfHop and c Western analysis of PfHop using anti-His antibodies.
The results are representative of at least three independent experiments
198 G.W. Gitau et al.Fig. 4 Localisation and expression of PfHop-GFP by parasites in
human red blood cells. a Localisation of PfHop in P. falciparum cells;
panels show a DIC image, nuclear stain (Hoechst), distribution of
PfHop, merge and overlay. b Panels show a DIC image, nuclear stain
(Hoechst), distribution of PfHop-GFP, merge and overlay. c Panels
show a DIC image, nucleus (Hoechst), distribution of PfHop-GFP,
distribution of PfHsp90, merge and overlay for PfHsp90–PfHop-GFP
co-localisation. d Panels show DIC image, stain (Hoechst), distribu-
tion of PfHop-GFP, distribution of PfHsp70, merge and overlay. e
Western blot analyses to confirm the expression of PfHop-GFP. First
panel, Western blot conducted using polyclonal anti-PfHop anti-
bodies; second panel, Western blot conducted using monoclonal anti-
GFP antibodies; and third panel, Western blot conducted as loading
control conducted using polyclonal anti-PfAldolase antibodies. The
results are representative of at least three independent experiments
Plasmodium falciparum Hsp70–Hsp90 organising protein 199further mirror the complexity of the mechanism by which
the Hsp70–Hop–Hsp90 pathway is governed. For example,
a non-canonical Hop protein with a missing TPR1 domain
from Caenorhabditis elegans (CeHop) has been described
as capable of binding both Hsp70 and Hsp90 through the
TPR2A domain (Gaiser et al. 2009). However, this essential
protein could not bind both Hsp70 and Hsp90 at once. This
could suggest that Hop may independently associate with
Hsp90 and Hsp70. Interestingly, none of the fractions we
obtained had PfHsp90 and PfHop in the absence of
PfHsp70, in spite of the fact that Hsp90 is known to
interact with Hop in the absence of Hsp70 (Hernández et al.
2002b). This may be due to the transient and dynamic
nature of the association between PfHsp90 and PfHop since
the immunofluorescence data suggested a strong associa-
tion between PfHsp90 and PfHop (Fig. 4b).
Previous studies proposed that Hsp40 co-chaperones
(belonging to the type I and type II subfamilies; Cheetham
and Caplan 1998) are involved in the assembly of the
Hsp70–Hop–Hsp90 complex (Cintron and Toft 2006). In
this study, we sought to investigate if PfJ4, a type II Hsp40
known to associate with PfHsp70 (Pesce et al. 2008), would
occur in the PfHsp70–PfHop–PfHsp90 complex. PfJ4 was
not eluted in the fraction in which both PfHsp70 and
PfHsp90 occurred (Fig. 5a). This suggests that PfJ4 may
not be involved in the formation of this complex. We
recently described a type I Hsp40 from P. falciparum
(PfHsp40) that functionally co-operates with PfHsp70 in
vitro (Botha et al. 2011). PfHsp40 may possibly be one of
the P. falciparum Hsp40 proteins that are involved in the
formation of the PfHsp70–PfHop complex, but this
possibility still needs to be experimentally verified.
Based on co-immunoprecipitation analysis, PfHsp70
associated with both PfHsp90 and PfHop (Fig. 5b). As
expected, in the absence of added ATP, PfHsp70 interacted
with more PfHop protein than in the presence of added ATP
(Fig. 5b). This is in agreement with a previous study that
proposed that Hop binds to Hsp70 when the latter is
Fig. 5 PfHop, PfHsp70,
PfHsp90 and PfJ4 may associate
in a heterologous complex. a
The presence of PfHop,
PfHsp70, PfHsp90 and PfJ4 in
the elution fractions obtained by
size exclusion chromatography
was determined by Western
analysis using corresponding
antibodies. Approximate molec-
ular weights (in kDa) associated
with select fractions are given
(top panel). b Co-
immunoprecipitation of PfHop,
PfHsp70 and PfHsp90 using
anti-PfHop antibodies, in the
absence and presence of ATP.
PfHop and immunoglobulin
heavy chain are shown by the
arrows. The results are repre-
sentative of at least three inde-
pendent experiments
200 G.W. Gitau et al.complexed to ADP (Johnson et al. 1998). It seems in the
presence of added ATP, less PfHsp90 was part of the
PfHsp70 complex than was involved in the formation of
this complex in the absence of added ATP (Fig 5b). Thus,
ATP may have inhibited the association between PfHsp70
and PfHop, resulting in less PfHsp90 protein associating
with PfHsp70. It seems that the possible association
between PfHop and PfHsp70 (Fig. 5b) was sensitive to
nucleotide, suggesting that PfHop and PfHsp70's associa-
tion represents a functional interaction.
A study by Famin and Ginsburg (2003), observed that
PfHsp70 and PfHsp90 both associate with ferriprotopor-
phyrin IX, a receptor of chloroquine that accumulates in
chloroquine treated parasites. Ferriprotoporphyrin IX is
thought to modulate the susceptibility of the parasite to
chloroquine (Fitch 1989). This suggests that PfHsp70 and
PfHsp90 may jointly facilitate the folding of proteins of
parasitic origin that are implicated in regulating antimalarial
drug efficacy. Interestingly, PfHsp90, PfHsp70 and PfHop
were previously found to be distinctly upregulated in a
group of clinical malaria patients (Pallavi et al. 2010). This
suggests that the expression of these proteins may share a
common regulatory trigger, and that their expression
correlates with clinical malaria progression. As further
evidence of their important role, plasmodial heat shock
proteins have been described as potential antimalarial drug
targets (reviewed in Pesce et al. (2010) and Shonhai (2010).
Plasmodial heat shock proteins may be targeted in
combination therapies by developing drugs that target these
molecules and other malarial protein drug targets that fold
through pathways that are facilitated by the parasite's
chaperone machinery (reviewed in Pesce et al. 2010;
Shonhai 2010).
The possible role of PfHop in coordinating the PfHsp70–
PfHsp90 functional pathway might lead to interesting
prospects in the search for alternative antimalarial therapies.
For example, some pyrimidinones with antimalarial activity
and are known to bind to the EEVD motif of Hsp70. These
compounds may be able to inhibit interaction of Hsp70
with its co-chaperones such as Hop, Hsp40 and client
substrates (Shonhai 2010). Thus, an understanding of the
PfHop mediation of PfHsp70–PfHsp90 pathway could
present a potential antimalarial drug target. This is
particularly an important pathway to target, as inhibition
of the Hsp70–Hsp90 pathway is known to lead to
degradation of client proteins that depend on this pathway
for folding (Whitesell and Lindquist 2005). Since both
PfHsp70 and Hsp90 play essential roles in the folding of
malarial proteins (Pavithra et al. 2007; Shonhai et al. 2007),
targeting this pathway has conceivable deleterious effects to
the parasite.
In conclusion, we have provided evidence that PfHop
potentially exists in association with PfHsp70 and PfHsp90.
Further studies need to be undertaken in order to under-
stand the mechanism by which PfHop modulates this
pathway in the malaria parasite and to understand if there
may be variations between the two pathways in the host
and malaria parasite towards the development of possible
malaria intervention strategies.
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